Vimarsana
Biggest News Aggregation in the World

Johnathan Napier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnathan Napier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnathan Napier Today - Breaking & Trending Today

Viewpoint: While African nations embrace GM and gene-edited crops to address climate change challenges, EU lags further behind, even as food prices soar - Vimarsana News

Viewpoint: While African nations embrace GM and gene-edited crops to address climate change challenges, EU lags further behind, even as food prices soar

While some richer nations dither over how to deal with biotech farming innovations, scientists in lower and middle income countries are seizing the opportunity to give agriculture a targeted genomic reboot.

Will England emerge as a world innovator in gene-edited crops? - Vimarsana News

Will England emerge as a world innovator in gene-edited crops?

Brexit has been a disaster for the UK.  It has not spurred the great economic revival that many of the Brexiters claimed it would. And many studies have indicated it will make the UK poorer over the long-term and deter investment. 

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q3 2023 Earnings Call Transcript - Vimarsana News

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q3 2023 Earnings Call Transcript

Operator: Hello and welcome to the Third Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience.

Omega-3 GM Camelina hits new commercialisation milestone - Vimarsana News

Omega-3 GM Camelina hits new commercialisation milestone

Yield10 Bioscience has signed a deal that will give it the exclusive licence to sell Omega-3 oils from the genetically modified

Yield10 sees 'significant market opportunities' for camelina derived omega-3 fatty acids - Vimarsana News

Yield10 sees 'significant market opportunities' for camelina derived omega-3 fatty acids

Yield10 Bioscience says it has exercised its option to finalize a global, commercial license to advanced omega-3 production technology from UK based Rothamsted Research.